Lagos ARV procurement marks a historic first as the state independently secures antiretroviral medicines for HIV patients, reducing donor reliance with first shipment due by end-August 2026
In Lagos, Nigeria, on Thursday 2 July 2026, Folakemi Animashaun, Chief Executive Officer of the Lagos State AIDS Control Agency, announced during a press briefing in Alausa, Ikeja, that the state would become the first sub-national government in Nigeria to independently procure antiretroviral medicines for people living with HIV, with the inaugural consignment expected before the end of August.
Also read: Nigeria receives Lenacapavir HIV prevention injection
This landmark step aims to reduce reliance on international donors and ensure uninterrupted access to life-saving treatment amid potential funding fluctuations.
Animashaun described the move as a historic milestone reflecting the unwavering commitment of Governor Babajide Sanwo-Olu’s administration to safeguarding residents’ health.
“We are pleased to inform Lagosians that the first consignment of these state-procured ARV medicines is expected to arrive in Lagos by the end of August 2026,” she said.
“This marks a historic milestone, making Lagos State the first sub-national government in Nigeria to independently procure antiretroviral medicines for people living with HIV.”
The announcement also addressed a recent Federal Ministry of Health report ranking Lagos highest in new HIV infections.
Animashaun challenged interpretations of the 10,430 figure, clarifying it represents newly diagnosed cases rather than new infections occurring within the year.
Many individuals may have contracted the virus years earlier but only recently tested, while others include referrals or those seeking care in the state’s robust healthcare system.
She stressed that true new infection rates rely on epidemiological modelling, not routine testing data alone.
“The figure widely reported in the media requires important technical interpretation,” Animashaun explained, warning that misreadings could fuel unnecessary fear, stigma, and reduced testing.
Programme data shared by the agency highlights progress. Lagos conducted over 504,800 HIV tests in 2025, identifying 11,940 positive cases with a 2.4 per cent positivity rate. In the first quarter of 2026, 179,229 tests yielded a lower 1.9 per cent positivity rate despite expanded efforts.
As of 2025, 147,904 people were on antiretroviral treatment, achieving 97 per cent viral suppression. The Early Infant Diagnosis positivity rate has fallen sharply from 5.1 per cent in 2020 to 1.5 per cent in 2025, signalling stronger prevention of mother-to-child transmission.
Lagos is also collaborating with the Joint United Nations Programme on HIV/AIDS to explore local production of antiretrovirals, drawing lessons from Kenya’s pharmaceutical management system. This would strengthen supply chains, reduce long-term costs, and enhance health security.
An HIV Response Acceleration Plan is underway from July to September 2026 across all local government areas, focusing on expanded testing, treatment retention, community prevention, and rollout of pre-exposure prophylaxis options.
Nigeria has made notable strides in its national HIV response over the years, yet challenges persist with donor dependency and varying state capacities.
Lagos’s proactive approach positions it as a potential model for sustainable domestic financing in public health.
Animashaun urged calm and action: “There is no cause for panic. Know your HIV status, access available prevention, testing, treatment and care services…
Also read: Kwara launches free Lenacapavir HIV prevention injection
HIV remains preventable and manageable. With early diagnosis and sustained treatment, people living with HIV can live long, healthy, productive and fulfilling lives.”
David Okere is a journalist and contributor to Freelanews.com, covering business, governance, public affairs, and human-interest stories with a commitment to accuracy, balance, and public interest reporting.
